Pactiv Evergreen Inc. Common stock
PTVE
PTVE was delisted on the 31st of March, 2025.
130 hedge funds and large institutions have $445M invested in Pactiv Evergreen Inc. Common stock in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 45 reducing their positions, and 16 closing their positions.
633% more call options, than puts
Call options by funds: $293K | Put options by funds: $40K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
33% more capital invested
Capital invested by funds: $334M → $445M (+$111M)
31% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 16
4% more funds holding
Funds holding: 125 → 130 (+5)
2% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 45
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$36.9M |
| 2 |
MVP
Medina Value Partners
Los Angeles,
California
|
+$11.1M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$9.69M |
| 4 |
Bank of New York Mellon
New York
|
+$8.97M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$3.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SHCM
Sachem Head Capital Management
New York
|
-$29.5M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$4.95M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$4.05M |
| 4 |
Millennium Management
New York
|
-$4.03M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$2.57M |
PTVE Hedge Fund Activity: Q4 2022 in Review
130 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q4 2022, worth a combined $445M — up 33% from $334M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new PTVE positions and 16 closed out — a net gain of 5 holders — while 44 added to existing stakes and 45 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $36.9M. The largest seller was Sachem Head Capital Management, exiting entirely with an estimated $29.5M sold.
- 130 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q4 2022, up from 125 in Q3 2022.
- Funds reported $445M of Pactiv Evergreen Inc. Common stock stock for Q4 2022, up 33% quarter-over-quarter.
- 21 funds opened new Pactiv Evergreen Inc. Common stock positions in Q4 2022 and 16 closed out, a net change of +5 holders.
- The largest Pactiv Evergreen Inc. Common stock buyer in Q4 2022 was Morgan Stanley, an estimated $36.9M added.
- The largest Pactiv Evergreen Inc. Common stock seller in Q4 2022 was Sachem Head Capital Management, an estimated $29.5M sold.
Based on aggregated 13F filings for Q4 2022.